首页> 外文OA文献 >Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

【2h】

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

机译：EGFR酪氨酸激酶抑制剂持续治疗作为局部治疗的EGFR突变晚期肺癌已获得对EGFR酪氨酸激酶抑制剂的耐药性。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yu Helena A.; Sima Camelia S.; Huang James; Solomon Stephen B.; Rimner Andreas; Paik Paul; Pietanza M. Catherine; Azzoli Christopher G.; Rizvi Naiyer A.; Krug Lee M.; Miller Vincent A.; Kris Mark G.; Riely Gregory J.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 第一代EGFR酪氨酸激酶抑制剂治疗106例复合EGFR突变肺癌患者:一项单中心临床研究 [J] . Xiangyang Yu, Xuewen Zhang, Zichen Zhang, 癌症（英文版） . 2019,第010期
2. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors [J] . YuH.A., SimaC.S., HuangJ., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2013,第3期

机译：EGFR酪氨酸激酶抑制剂持续治疗作为局部治疗，已发展为对EGFR酪氨酸激酶抑制剂产生耐药性的EGFR突变晚期肺癌
3. Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports [J] . Xuefei Shi, Jia Zhou, Caihua Qian, OncoTargets and therapy . 2020,第2期

机译：持续EGFR酪氨酸激酶抑制剂治疗的射频消融促进EGFR-突变生物晚期肺癌的疾病对照，获得EGFR酪氨酸激酶抑制剂的抗性：两种情况报告
4. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study [J] . Ni Yang, Bi Jingwang, Ye Xin, Medicine. . 2016,第25期

机译：EGFR酪氨酸激酶抑制剂的局部微波消融作为晚期非小细胞肺癌的治疗策略，该晚期非小细胞肺癌在EGFR酪氨酸激酶抑制剂的治疗过程中发展为中枢神经系统寡聚进展性疾病：一项先导研究
5. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
6. Targeting EGFR and ErbB2 by small molecule tyrosine kinase inhibitors in human colon cancer. [D] . Zhou, Yunfei. 2005

机译：小分子酪氨酸激酶抑制剂在人结肠癌中靶向EGFR和ErbB2。
7. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors [O] . Helena A. Yu, Camelia S. Sima, James Huang, -1

机译：局部治疗与持续EGFR酪氨酸激酶抑制剂治疗作为EGFR突变先进肺癌治疗策略已经发展到获得的EGFR酪氨酸激酶抑制剂的抗性
8. >Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports [O] . Xuefei Shi, Jia Zhou, Caihua Qian, 2020

机译：>持续EGFR酪氨酸激酶抑制剂治疗促进EGFR-突变体肺癌的疾病控制，具有抗EGFR酪氨酸激酶抑制剂的抗性：两病例报告
9. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅